Princeton Global Asset Management’s Biogen BIIB Stock Holding History

Princeton Global Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-74	Closed	-$17.2K	–	668
2024 Q2	$17.2K	Buy	+74	New	+$16.1K	﹤0.01%	405
2019 Q3	–	Sell	-950	Closed	-$222K	–	350
2019 Q2	$222K	Hold	950	–	–	0.13%	140
2019 Q1	$224K	Buy	950 +120	+14%	+$37.8K	0.15%	131
2018 Q4	$250K	Buy	+830	New	+$265K	0.22%	105

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Princeton Global Asset Management's BIIB Position: Q3 2024 in Review

Princeton Global Asset Management sold out of Biogen (BIIB) in Q3 2024, closing a stake of 74 shares — an estimated $17.2K sold.

Princeton Global Asset Management first reported a position in BIIB in Q4 2018 and held it in 4 quarters. The position peaked at $250K in Q4 2018. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

Princeton Global Asset Management reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
Princeton Global Asset Management sold 74 Biogen shares in Q3 2024, an estimated $17.2K.
Princeton Global Asset Management first reported a position in Biogen in Q4 2018 and held it in 4 quarters.
Princeton Global Asset Management's Biogen position peaked at $250K in Q4 2018.
916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Princeton Global Asset Management's 13F filing for Q3 2024, filed 29 Oct 2024.